AMH and chronic obstructive pulmonary disease: These findings explain the molecular mechanism underlying the therapeutic effects of XFPC capsules in COPD-induced AMH, provide novel therapeutic targets, and offer a scientific foundation for the development effective treatments for COPD, which has important implications for lessening the burden on patients and society.